About
Advisor supporting the biopharmaceutical team since 2025 and CEO of IFM Therapeutics. He previously served as Global Head of BD&L for the Novartis Institutes for Biomedical Research and led NIBR's Genomics Institute.
Colleagues at Lightstone Ventures
Brendan Kelly
Principal at Lightstone Ventures
Brendan Kelly, Ph.D.
Principal at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
Frequently asked questions
- Where does H. Martin Seidel work?
- H. Martin Seidel is Advisor at Lightstone Ventures.



